Clinical Validation of the Unparalleled Sensitivity of the Novel Allele-Discriminating Priming System Technology-Based EGFR Mutation Assay in Patients with Operable Non-Small Cell Lung Cancer.
Autor: | Il-Hyun Park1, Dae-Soon Son2, Yoon-La Choi3, Ji-Hyeon Choi1, Ji-Eun Park1, Yeong Jeong Jeon4, Minseob Cho2, Hong Kwan Kim4, Yong Soo Choi4, Young Mog Shim4, Jung Hee Kang4, Suzy Park4, Jinseon Lee4, Sung-Hyun Kim4, Byung-Chul Lee1 bclee1101@genecast.co.kr, Jhingook Kim4 jkimsmc@skku.edu |
---|---|
Zdroj: | Cancer Research & Treatment. Jan2024, Vol. 56 Issue 1, p81-91. 11p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |